RELATING RSV GENETIC DIVERSITY TO GLOBAL TRANSMISSION DYNAMICS by Fisk, Rebecca J
The Texas Medical Center Library
DigitalCommons@TMC
UT School of Public Health Dissertations (Open
Access) School of Public Health
Fall 12-2018
RELATING RSV GENETIC DIVERSITY TO
GLOBAL TRANSMISSION DYNAMICS
Rebecca J. Fisk
UTHealth School of Public Health, becca.fisk@gmail.com
Follow this and additional works at: https://digitalcommons.library.tmc.edu/uthsph_dissertsopen
Part of the Community Psychology Commons, Health Psychology Commons, and the Public
Health Commons
This is brought to you for free and open access by the School of Public
Health at DigitalCommons@TMC. It has been accepted for inclusion in
UT School of Public Health Dissertations (Open Access) by an authorized
administrator of DigitalCommons@TMC. For more information, please
contact nha.huynh@library.tmc.edu.
Footer Logo
Recommended Citation
Fisk, Rebecca J., "RELATING RSV GENETIC DIVERSITY TO GLOBAL TRANSMISSION DYNAMICS" (2018). UT School of
Public Health Dissertations (Open Access). 10.
https://digitalcommons.library.tmc.edu/uthsph_dissertsopen/10

Copyright  
by 
Rebecca J Fisk, BS, MPH 
 2018  
 
 
  
 
 RELATING RESPIRATORY SYNCYTIAL VIRUS GENETIC DIVERSITY TO GLOBAL 
TRANSMISSION DYNAMICS AND DISEASE SEVERITY  
 
 
 
by 
 
REBECCA J FISK 
BS, College of William & Mary, 2015 
 
 
 
 
Presented to the Faculty of The University of Texas 
School of Public Health  
in Partial Fulfillment 
of the Requirements  
for the Degree of 
 
MASTER OF PUBLIC HEALTH  
 
 
 
 
THE UNIVERSITY OF TEXAS  
SCHOOL OF PUBLIC HEALTH 
Houston, Texas 
December, 2018 
  
ACKNOWLEDGEMENTS 
 I would like to thank Dr. Bahl for allowing me to work with him and his team and for 
introducing me to this project. I would like to thank Xueting Qiu for all of her help with this 
thesis and for her guidance throughout the design and implementation of the study. In 
addition, I would like to thank Dr. Pedro Piedra at Baylor College of Medicine and Dr. 
Lorena Tapia at the University of Chile for sharing the RSV genomic data from Houston and 
Chile. Thank you to Dr. Blake Hanson for allowing me to continue using the project room. I 
would also like to thank Alex Hoffman and Olivia Walton for all of their support throughout 
this process.   
  
 RELATING RESPIRATORY SYNCYTIAL VIRUS GENETIC DIVERSITY TO GLOBAL 
TRANSMISSION DYNAMICS AND DISEASE SEVERITY  
 
 
Rebecca J Fisk, BS, MPH 
The University of Texas  
School of Public Health, 2018 
 
  
CE/Thesis/Dissertation Chair:  Craig L Hanis, PhD  
 
Many studies of Respiratory Syncytial Virus (RSV) have relied on analyses of the 
Major Surface Glycoprotein G gene (G gene). Global transmission patterns have not been 
well studied due to lack of systematic global surveillance efforts. This study used 
phylogenetic analysis of full genome data, categorized by geo-region, to determine the 
sources of RSV A and B infection in Chile and Houston, Texas. Additionally, disease 
severity studies have generally focused on outcomes associated with a single genotype. In 
this study we developed a statistical phylogenetic approach to explore the relationship 
between tree topology and disease severity. Disease severity data included if the patient was 
given oxygen, if they were hospitalized, and if they were admitted to an intensive care unit.  
Global data was downloaded from GenBank, separated into RSV A and RSV B, 
aligned, and manually optimized. The United States and Canada region was overrepresented 
in the publicly available data, so subsampling was conducted to reduce selection bias. 
Starting trees were generated from the subsampled datasets using RAxML. Geographic traits 
and trait state transition rates were jointly estimated in a Bayesian statistical framework using 
BEAST. The global transmission network was estimated using the Bayesian stochastic search 
variable selection and a constant population with a HKY genetic substitution model. Trait 
associations were calculated using BaTS.  
For RSV A, the time to most recent common ancestor (tMRCA) was 1963.40 (95% 
BCI: 1946.15, 1969.60). For RSV B, the tMRCA was 1963.80 (95% BCI: 1959.50, 1967.33).  
Europe and Central Asia was a key source of RSV A and B transmissions for both Chile and 
Houston.  In addition, the Middle East and North Africa and Latin America and the 
Caribbean were sources of RSV transmission into Houston. For the RSV A clinical data, 
there were significant associations between disease severity and tree topology when 
analyzing all three traits together (AI 3.13 p<0.01, PS 22.39 p<0.01) and for oxygen (AI 0.98 
p<0.01, PS 9.32 p<0.01) and hospitalization independently (AI 1.92 p<0.01, PS 11.78 
p<0.01). No significant association was found between tree topology and ICU admission. No 
significant associations were found in the RSV B clinical data, which may be due to the 
small sample size and homogeneous outcomes in this group.  
Improved surveillance systems are needed to gain a better understanding of global 
transmission patterns to complement studies done of local transmission patterns, as global 
introductions play an important role in local outbreaks. Identifying genetic mutations that 
lead to more severe outcomes may help researchers target vaccine development.  
 
 
 
 
TABLE OF CONTENTS 
List of Tables ............................................................................................................................. i 
List of Figures ........................................................................................................................... ii 
List of Appendices ................................................................................................................... iii 
Background ................................................................................................................................1 
Literature Review.................................................................................................................1 
RSV Genome and Genotypes ........................................................................................1 
Epidemiology .................................................................................................................3 
Molecular Epidemiology and Global Transmission ......................................................6 
Patterns in Severity of Disease ......................................................................................8 
Knowledge Gaps ..........................................................................................................11 
Public Health Significance .................................................................................................11 
Specific Aims .....................................................................................................................13 
Methods....................................................................................................................................15 
Study Population & Data Set Compilation ........................................................................15 
Maximum Likelihood Phylogenetic Analysis ...................................................................17 
Bayesian Phylogenetic Analysis ........................................................................................17 
Discrete phylogeographical analysis..................................................................................18 
Bayesian Tip-Association Significance Testing Analysis .................................................20 
Ethics Statement.................................................................................................................21 
Results ......................................................................................................................................22 
Global Transmission Dynamics .........................................................................................22 
Global Distribution of RSV Samples ...........................................................................22 
Bayesian Phylogenetic Analysis ..................................................................................23 
RSV Global Transmission Patterns .............................................................................26 
Markov Jump Counts ...................................................................................................28 
Clinical Severity Analyses .................................................................................................30 
Clinical Data Description .............................................................................................30 
Bayesian Phylogenetic Analysis of Clinical Data .......................................................30 
Clustering Analysis of Clinical Severity......................................................................32 
Discussion ................................................................................................................................35 
Conclusion ...............................................................................................................................41 
Appendices ...............................................................................................................................43 
References ................................................................................................................................46 
 
i 
 
LIST OF TABLES 
Table 1. Number of Cases by Disease Severity Traits for RSV A and RSV B .......................30 
Table 2. Clustering of Disease Severity Traits for RSV A ......................................................33 
Table 3. Clustering of Disease Severity Traits for RSV B ......................................................34 
Table B1. Rates and Level of Support for RSV A Transmission ............................................43 
Table B2. Rates and Level of Support for RSV B Transmission ............................................45 
 
 
 
  
ii 
 
LIST OF FIGURES  
Figure 1. Distribution of Subsampled Sequences by Geo-Region ..........................................23 
Figure 2. Bayesian Maximum Clade Credibility Tree for Global RSV A...............................24 
Figure 3. Bayesian Maximum Clade Credibility Tree for Global RSV B ...............................25 
Figure 4. Map of Global Transmission Rates for RSV A ........................................................26 
Figure 5. Map of Global Transmission Rates for RSV B ........................................................28 
Figure 6. Markov Jump Count Heat Map for RSV A ..............................................................29 
Figure 7. Markov Jump Count Heat Map for RSV B ..............................................................29 
Figure 8. Clinical Maximum Clade Credibility Trees for RSV A ...........................................31 
Figure 9. Clinical Maximum Clade Credibility Trees for RSV B ...........................................32 
Figure A1. Distribution of Sequences by Geo-Region for RSV A(a) and RSV B(b) .............43 
 
 
iii 
 
LIST OF APPENDICES 
Appendix A:  Distribution of Global RSV Samples ................................................................43 
Appendix B:  Transmission Rates for RSV and Level of Support ..........................................43 
 
 
 
  
1 
 
BACKGROUND  
Literature Review  
Respiratory Syncytial Virus (RSV) was first isolated in 1956 in Chimpanzees by Dr. 
J.A. Morris and colleagues (Orga, 2004). It was isolated from humans for the first time later 
that year from two infants, one with pneumonia and one with croup (Chanock, et al., 1962). 
One of the first RSV epidemiological studies in 1962 noted that “RS virus appears to become 
disseminated extensively in the pediatric population every year (Chanock, et al., 1962).” 
Today we have more information on the epidemiology of the disease and its ubiquitous 
nature; it is estimated that almost every child has been infected by the age of two (Bont, et 
al., 2016). In the era of genetic sequencing, efforts to study transmission and severity through 
phylogenetics originally focused on partial sequencing of the G gene, which codes for the 
attachment glycoprotein (Schobel, et al., 2016), but the focus has recently shifted to 
collecting and using full genome data in analyses to better understand transmission dynamics 
not readily apparent in traditional epidemiologic and G gene data. 
RSV Genome and Genotypes 
RSV is an enveloped, negative-sense, single-stranded RNA virus, with a non-
segmented genome that is about 15,000 nucleotides long (Borchers, et al., 2013). Along with 
the mumps virus and parainfluenza, RSV is a member of the Paramyxoviridae family and of 
the genus Pneumovirus. The virus has two major antigenic types, A and B, which are 
classified by differences in reaction to monoclonal antibodies, although there is significant 
genetic variability within each group (Duvvuri, et al., 2015; Orga, 2004).   
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The RSV genome has 10 genes that code for 11 proteins (Schobel, et al., 2016). 
Genes G, F, and SH code respectively for attachment glycoprotein, fusion glycoprotein, and 
small hydrophobic protein, which play roles in viral attachment and entry to host cells 
(McLellan, Ray, & Peeples, 2013; Tan, et al., 2013). The remaining genes code for 
nonstructural proteins (NS1 and NS2), nucleocapsid protein (N), phosphoprotein (P), matrix 
protein (M), transcription regulators (M2-1 and M2-2), and large polymerase (L) (Schobel, et 
al., 2016; Tan, et al., 2013). 
The G gene produces the key surface glycoprotein in viral binding to host cells and is 
often called the attachment protein (McLellan, Ray, & Peeples, 2013). This gene has 
traditionally been the focus of studies on the evolutionary history of RSV because there is a 
hypervariable region at the C-terminus that contains most of the genetic variation in the 
genome (Schobel, et al., 2016). Before whole genome sequencing for RSV was widespread, 
it was easier to base analyses on this section of the gene since it was thought to be the 
location demonstrating most evolutionary signals (Schobel, et al., 2016). It has also been 
suggested that the lack of cross-immunity between types and genotypes is due to variation in 
the G gene (Tan, et al., 2013). Genotypes of RSV are currently classified by this 
hypervariable region in the G gene (Hibino, et al., 2018). There has been disagreement on the 
classification and naming of RSV genotypes, but there are two that are easily identified due 
to insertions in the G gene: RSV A genotype ON1 and RSV B genotype BA.  RSV A 
genotype ON1 has a 72-nucleotide duplication that is not present in other common A 
genotypes, such as NA1 and GA2 (Schobel, et al., 2016). RSV B genotype BA has a similar 
duplication in the same region that is 60-nucleotides long, this duplication is also missing in 
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other genotypes of B (Schobel, et al., 2016). ON1 and BA have been the dominant genotypes 
in recent outbreaks (Cui, et al., 2013; Tabatabai, et al., 2014).  
The F gene, which is sometimes analyzed in conjunction with the G gene, codes for 
another surface glycoprotein that is key to viral entry to host cells (Schobel, et al., 2016). 
This protein has a pre-fusion form and a post-fusion form, and critical antigenic sites in the 
protein have been used in vaccine design (Hause, et al., 2017). Compared to G gene, the F 
gene is well-conserved across all genotypes of both RSV A and B (McLellan, Ray, and 
Peeples, 2013). A study conducted by Hause and colleagues found more genetic variability 
than previously thought, especially in the pre-fusion antigenic sites, and more variations in 
RSV B sequences than RSV A sequences (2017). Another gene that plays a role in viral entry 
and is often not included in epidemiologic analyses is the SH gene. SH codes for the small 
hydrophobic protein that changes the permeability of the host membrane and aids in viral 
entry to host cells, although it is not necessary for entry (Tan, et al., 2013).  
Epidemiology 
In temperate climates, RSV circulation shows seasonal patterns similar to seasonal 
influenza, with peaks in the winter months and fewer infections in the summer. In the 
Northern Hemisphere, the season normally starts in October or November and ends in March 
or April, with an epidemic peak occurring between December and February (Bont, et al., 
2016). Like influenza, RSV can spread through aerosolized droplets generated by coughs or 
sneezes, and the virus is able to live on hard surfaces for several hours (CDC, 2017). 
According to the US Centers for Disease Control and Prevention (CDC), children are most 
often exposed to the virus at school or day-care and then cause household transmission 
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(CDC, 2017). Historical data are largely focused on the United States, although more recent 
studies on the epidemiology of RSV have been conducted in a large number of countries 
around the world. Increasing the number of countries and regions represented in the publicly 
available dataset makes it possible to study the larger patterns of disease transmission. 
RSV infections usually cause mild, cold-like signs and symptoms, but high-risk 
populations can develop more severe complications, including bronchiolitis, pneumonia, 
and/or death. RSV “has a propensity for causing bronchiolitis,” and often produces a form of 
the disease that is longer in duration and more severe than bronchiolitis from other causes 
(Pickles & DeVincenzo, 2017). High-risk populations listed by the CDC include infants 
under 6 months of age, infants born prematurely, especially if the infant has chronic lung or 
heart disease, children with reduced immune function, and adults over the age of 65, 
especially those with weakened immune system or chronic heart or lung disease (CDC, 
2017). Although the risk of severe complication requiring hospitalization is higher in infants 
with chronic diseases and premature birth at the individual level, the majority of admissions 
occur in children who are not high-risk (Bont, et al., 2016). Over 70% of pediatric hospital 
admissions for RSV have no underlying medical conditions, so although their individual risk 
is lower, previously healthy children make up the majority of cases (Bont, et al., 2016).  
A meta-analysis of all available epidemiologic studies on RSV to determine its global 
impacts, conducted by Shi and colleagues, found that 22% of all severe cases of acute lower 
respiratory infections were due to RSV in children under the age of 5, resulting in around 3.2 
million hospitalizations and 59,600 deaths in hospitals (2017). Almost half of the 
hospitalizations and deaths, 1.4 million and 27,300 respectively, occurred in children under 
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six months of age (Shi, et al., 2017). The original Global Burden of Disease Study estimated 
that 6.7% of all deaths in children 1 month to 1 year old were due to RSV, as were 1.6% of 
all deaths in children ages 1 to 4 (Lozano, et al., 2012). The rate of hospitalization and case 
fatality rates within hospitals varied by the country’s income level as defined by the World 
Bank. Lower hospitalization rates were found in low income countries and rates increased as 
the economic situation of the country improved (Shi, et al., 2017). Two reasons for this 
discrepancy is poor access to care in resource constrained locations, and poor care-seeking 
behavior, although Shi and colleagues do not state whether this is due to a family’s inability 
to pay or mistrust of the medical system (2017). Case fatality rates trended in the opposite 
direction; death rates were higher in low income countries and the rates decreased as income 
status increased (Shi, et al., 2017).   
To date, the Shi study has been one of the most comprehensive reviews of the burden 
of RSV globally, although it is likely that the true burden of the disease has been 
underestimated because the study only counted cases that were admitted to the hospital. In 
places where access to medical care is limited, patients may not be able to go the hospital and 
those cases would go unreported and unaccounted for in this burden analysis. The 
underestimation is compounded by gaps in the data, as there are many areas of the world 
where data on RSV have not been collected (Shi, et al., 2017). To address this problem, the 
World Health Organization launched the Global RSV Surveillance pilot, which “aims to test 
the feasibility of leveraging the Global Influenza Surveillance and Response System platform 
for RSV surveillance without adversely affecting the well-established surveillance of 
influenza (WHO, 2017).” More data on the distribution of RSV and its molecular 
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epidemiology will aid efforts to better understand the transmission patterns and determinants 
of disease in order to better control its spread, and eventually to design effective RSV 
vaccines (WHO, 2017). 
Molecular Epidemiology and Global Transmission 
Many studies have focused on local circulation patterns of RSV genotypes across 
seasons or within a single season using local surveillance data (Hibino, et al., 2018; de-Paris, 
et al., 2014; Esposito, et al., 2015; Tran, et al., 2013; Panayiotou, et al., 2014). The dominant 
type can alternate between A and B across seasons, and the dominant genotypes can also 
change across seasons. For example, RSV A genotype NA1 was the dominant type in Japan 
before the introduction of ON1, which then became the dominant genotype (Hibino, et al., 
2018). Multiple genotypes from both RSV A and B types can circulate concurrently within a 
single season, increasing the complexity of circulation patterns. (Schobel, et al., 2016). Many 
studies conducted on the distribution of RSV focus on identifying the dominant and co-
circulating genotypes in one location and provide limited analysis of the geographic 
transmission (Hibino, et al., 2018; de-Paris, et al., 2014; Esposito, et al., 2015; Tran, et al., 
2013). Very few studies connect this local data to publicly available global data to place local 
outbreaks in the context of the larger phylogenic tree, which would allow investigators to 
make inferences about the source of the disease in their country or locality and about global 
transmission patterns.   
Global transmission patterns have not been well studied due to lack of systematic 
global surveillance efforts and the resulting large gaps in the information available to 
investigators (Duvvuri, et al., 2015; Zou, et al., 2016). One of the few studies to take the 
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global view, focused only on the distribution of the ON1 genotypes, as defined by the G gene 
(Duvvuri, et al., 2015). They estimated that ON1 emerged in 2007 or 2008 in Ontario, 
Canada, and by the time the study was conducted it had been detected on every continent 
(Duvvuri, et al., 2015). The phylogenic tree produced in the study did not appear to show a 
strong association between clade and geography, although this could be due to the limited 
amount of data available (Duvvuri, et al., 2015). Duvvuri and colleagues suggested that 
irregular clusters, such as one including Canada, United States, Thailand, and Italy, could be 
due to patterns in travel (2015). One limitation of this study is that they used data only on the 
second hypervariable region of the G gene, instead of using a whole genome approach to 
infer global patterns (Duvvuri, et al., 2015). 
Another study analyzing sequences from Guangdong, China, in conjunction with 
sequences from publicly available strains indicated the dominant strains GA2 and ON1 
originated in the Americas before spreading to other regions (Zou, et al., 2016). The 
investigators noted that this result could be due to bias in the dataset, since most early 
samples are from the United States and much of the available data is also from this country 
(Zou, et al., 2016). In the phylogenetic tree generated by the study, they found that many 
clades contained viral strains from multiple geographic areas, but several clades represented 
only Guangdong (Zou, et al., 2016). This indicates that there were introductions of RSV from 
other regions, but seasonal epidemics may also have been seeded by locally persistent strains 
of the virus (Zou, et al., 2016). However, analyses are biased towards identifying local 
persistence because of a lack of information from other regions (Zou, et al., 2016).  
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The Zou study had two main limitations: their analysis relied on just G gene 
sequences, similar to many other molecular epidemiologic studies; and their geographic 
analyses relied on four large regions, which limits the utility of the findings (Zou, et al., 
2016). Reliance on the G gene does not present the whole evolutionary history of the virus, 
but RSV whole genome analyses are rare. One study conducted by Bose and colleagues 
found a similar pattern to Zou (2016). Their analysis found several genotypes were 
circulating simultaneous across the globe, but that some rarer genotypes were only found 
within one area; which is probably due to inconsistent surveillance around the world as these 
rare genotypes were found in areas with more data (Bose, et al., 2015). Unlike the Zou study, 
Bose and colleagues did not note a strong relationship between geographic location and 
clades on the phylogenic tree, which indicates that RSV is not evolving independently and 
separately in one locale and there is interaction between regions (Bose, et al., 2015).  
As more whole genome data has become available and more advanced 
phylogeographic methods are developed, global transmission patterns of RSV can be better 
explored. Understanding both local and global dynamics using a phylogeographic approach 
will reveal the relative importance of international introductions in these seasonal epidemics 
and inform surveillance programs and control measures in the future.  
Patterns in Severity of Disease 
Although much attention has been paid to the severity of RSV infection in relation to 
host factors, such as immunosuppression or chronic health conditions, many studies indicate 
that severity is related to more than just host factors. Some viral genome characteristics can 
also be important determinants of viral pathogenicity, resulting in different levels of disease 
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severity. However, viral genetic characteristics and RSV pathogenicity have not been well 
connected. Most studies focus on the relationship between disease severity and RSV 
genotype with inconsistent results. One such study conducted over three epidemic seasons in 
Japan found that 35.6% of those infected with ON1 were hospitalized, indicating more severe 
disease, and this proportion was greater than all other measured genotype hospitalization 
rates (Hibino, et al., 2018). The odds ratio of hospitalization for those infected with ON1 to 
those infected with NA1 was 6.92:1, and there was no significant difference in the odds of 
hospitalization between NA1, BA9, and BA10 infections (Hibino, et al., 2018). Yoshihara 
and colleagues found similar results in Vietnam, where the risk of lower respiratory tract 
infections was 2.26 times higher in those with ON1 compared to those with NA1 (2016). 
This is opposed by results from a study in Northern Italy, in which NA1 was more likely to 
cause upper respiratory tract infections and require hospitalizations than ON1 (Esposito, et 
al., 2015). In a population where ON1 was not detected, Luchsinger and colleagues found 
that infection with NA1 was more likely to cause hospitalization and severe disease than two 
RSV B genotypes (2014). In Cyprus, researchers found that RSV A genotype GA2 and RSV 
B genotype BA both caused more severe disease than ON1 (Panayiotou, et al., 2014). They 
also found that a larger proportion of those infected with BA required oxygen, suggesting BA 
causes severe outcomes more frequently than other genotypes, in contrast to common results 
indicating that RSV A is more likely to cause severe disease (Panayiotou, et al., 2014). 
Espinosa and colleagues also looked for a relationship between genotype and disease severity 
in Chile but did not find any significant interaction between viral type or genotype and 
disease severity (2017). 
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Since multiple studies have yielded mixed results, the links between genetic 
characteristics of RSV and disease severity are equivocal. Many studies have focused on 
relating genotype to severity, but these studies have been inconclusive due to limited sample 
size and the large variations within genotypes. The reliance on just the G gene in genotyping 
may also play a role in the muddled findings, since other genes inducing host immune 
responses are ignored. These other genes, especially the F gene, may have important genetic 
differences that lead to differences in disease severity, but these characteristics have not yet 
been identified because a genomic approach has rarely been applied in these analyses.   
A few studies on differences of disease severity among RSV strains have been 
conducted in vitro, which reported different levels of cytokine activation across strains, but 
not across genotypes. Levitz and colleagues (2012) studied the effects of different strains 
collected from patients to produce varying inflammatory cytokine (IL-6) responses. An 
increase in IL-6 production is part of the body’s immune response to RSV infection. Their 
analysis focused on RSV A, genotypes GA2, GA3, GA4, and RSV B and found that the level 
of IL-6, an inflammatory cytokine, varied greatly across strains within the same genotype, 
between RSVA and B, and by genotypes at the same level (Levitz, et al., 2012). A similar 
study by Thompson and colleagues (2015) observed disease severity in patients and 
compared severity with in vitro cytokine induction for four cytokines (IL-1α, IL-6, IL-8 and 
RANTES). There was no significant difference between strains in IL-6 levels, which differs 
from the results of the Levitz study, but instead there were significant differences between 
strains in the production of two other inflammatory cytokines, IL-8 and RANTES (Levitz, 
2012; Thompson, et al., 2015). There were no significant trends in activation of cytokines 
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across RSV types and genotypes, in contrast to many studies on disease severity which focus 
on genotyping discussed above (Thompson, et al., 2015; Hibino, et al., 2018; Esposito, et al., 
2015; Panayiotou, et al., 2014). These data support the use of full genome data when 
investigating the connection between disease severity and the strain of RSV, since few trends 
were seen across genotypes, which indicates that the genetic predictor of disease severity 
could be located in another part of the genome. 
Knowledge Gaps  
In summary, we have identified two major gaps in the literature on RSV transmission 
and disease severity: 1) RSV whole genome data has not been used for inferring global 
transmission patterns, and current studies rely solely on the G gene, so incomplete lineage 
sorting could be a confounding variable in relationships proposed by most of these studies; 2) 
RSV disease severity has been mostly studied at the genotype level, but strain-specific 
genetic characteristics have not been explored. These two gaps are critical to understanding 
the epidemiology and burden of RSV. A better understanding of RSV transmission patterns 
will help inform prevention strategies, and genetic characteristics related to disease severity 
could provide valuable information for antiviral drug and vaccine design.  
 
Public Health Significance 
RSV is important to public health because of its ubiquitous nature and the potential 
for severe complications in high-risk populations, including children under the age of 5 and 
adults over the age of 65. Assessments of the impact of RSV have focused on young 
children, so the burden of disease in the elderly often has been overlooked. It is estimated 
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that close to 60,000 hospitalizations each year in the United States could be attributed to RSV 
in children 5 years old and younger, and half a million emergency room visits every year 
(Breese Hall, et al., 2009). The number of hospitalizations of those over the age of 64 was 
estimated to be 180,000 per year in the United States, close to three times the number in 
children (Falsey, et al., 2005). A review of insurance claims data showed that the expense of 
hospital stays related to RSV was significantly higher than the cost for non-RSV controls 
across all age categories except for patients ages 5 to 17 (Amand, et al., 2018). The highest 
discrepancy in cost occurred in those ages 75 to 84, where an average of $17,211 was spent 
on non-RSV controls and an average of $40,405 was spent on RSV cases (Amand, et al., 
2018). These estimates do not include outpatient costs or lost productivity, so there is a large 
economic impact in addition to the burden on healthcare utilization (Amand, et al., 2018; 
Falsey, et al., 2005). 
It is estimated that almost everyone has been infected by the age of two, but this 
history of infection does not induce lifelong immunity (Brochers, et al., 2013). Since no 
vaccine currently exists, although there are several in various clinical stages of development, 
it is especially important to understand global and local transmission dynamics to inform 
infection control measures. In this study, we propose to explore the RSV strains from Chile 
and Houston, Texas, in the context of global transmission patterns inferred from publicly 
available full genome data to identify potential sources of infection during seasonal 
outbreaks. Chile and Houston were selected due to collaboration agreements between 
investigators at Baylor College of Medicine, University of Chile College of Medicine, and 
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Dr. Bahl at the University of Texas Health Sciences Center. These data will facilitate further 
exploration of transmission paths between geo-regions and inform prevention strategies.  
Viral genetic information paired with patient outcome information can elucidate the 
relation between the genetic characteristics of RSV and disease severity to target vaccine 
development on strains with the highest contributions to the burden of disease.  Although 
host factors, viral dose, and region of the lung infected all play important roles in the severity 
of disease, it is equally important to understand strain specific responses and severity since 
previous in vitro and epidemiological studies have investigated the link between RSV 
genotype and disease severity. The strains collected from Chile and Houston include 
information on patient outcomes (if the patient needed oxygen and admission to a hospital or 
intensive care unit), so clusters or specific genetic characteristics that are associated with 
high disease severity can be identified.  
 
Specific Aims  
Previously, much attention has been paid to local patterns of RSV infection and 
disease severity by genotype because local transmission was not well understood. Many of 
these studies indicate that dominant genotypes that were not previously present in their area 
were introduced from an outside source. As the understanding of local dynamics has 
improved and the amount of global data have increased, it has become possible to investigate 
transmission dynamics on a larger scale. Studies on these global patterns indicate that there is 
a mixture of local persistence and global introduction of RSV based on the G gene only, but 
no studies so far have tried to apply a source-sink model with RSV full genome data to infer 
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the global transmission pattern. Studies of disease severity have also focused on identifying 
the genotypes that caused the largest number of most severe cases, which has led to 
inconsistent conclusions due to the diversity within each genotype, and no studies have been 
conducted to investigate the relationships between strain-specific genetic characteristics and 
disease severity via the phylogenetic approach. With publicly available full-genome data 
from around the world, the samples from Chile and Houston, Texas, and detailed data of 
disease severity, we want to answer the questions: 1) What is the RSV global transmission 
pattern? 2) What are the sources of RSV samples collected in Chile and Houston, Texas 
between 1987 and 2014? 3) Are certain viral genetic characteristics associated with 
hospitalization and ICU admission in Chile and Houston? This information can help inform 
surveillance strategies, similar to what has been done with influenza, and help target vaccine 
development to protect against genetic characteristics associated with more severe outcomes.  
 Specific Aims:  
1. To understand where the isolates from Chile and Houston are located in the global 
tree and identify global transmission patterns using phylodynamic source-sink 
modeling. 
2. To explore the correlation between viral genetic characteristics and severe 
outcomes with clustering analyses. 
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METHODS 
Study Population & Data Set Compilation 
All publicly available RSV sequences with over 5,000 nucleotides were downloaded 
from GenBank (https://www.ncbi.nlm.nih.gov/genbank/). The accession numbers for each 
sequence were downloaded manually. Geographic and collection date information was 
abstracted from the textual and tabular contents of full-text publications by employing 
GeoBoost, which is a Java program to extract and normalize the location of infected host of 
viruses from the metadata files and related published records (Tahsin, et al., 2017). The 
associated metadata, including the date of collection and geographic data was matched with 
sequence data from GenBank via its unique accession number.  
The G, F, and SH gene data with detailed information on disease severity from Chile 
and Houston was shared by the collaborating investigators in Houston and Chile. Data from 
Houston were collected from children with lower respiratory infections between 1987 and 
2005. These samples have been used previously to study the genetic variability of the G, F, 
and SH genes (Tapia, et al., 2014). The data from Santiago de Chile were collected as part of 
a study investigating the effect of sequence variation of the G, F, and SH genes on immune 
response and disease severity (Tapia, et al., 2012). Older sequences from Chile are from 1990 
to 2010 and were sampled from the biorepository at the University of Chile. Strains from 
2010 to 2014 were taken from a cohort of RSV infected infants at Hospital Roberto del Rio 
during these outbreaks. Tapia and colleagues also conducted a chart review to abstract 
information on the patient’s age, sex, and disease severity. Disease severity was evaluated 
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with three dichotomous variables: given oxygen therapy, hospitalization, and admission to 
the intensive care unit (ICU). 
The full dataset from publicly available data and from collaborators was then 
separated into RSV A and RSV B for alignment and manual optimization. The data were 
aligned using MUSCLE v3.8.31 (Edgar, 2004). The aligned data were reviewed and cleaned 
using BioEdit (Hall, 2005). Manual optimization of the alignment was then conducted to 
correct artificial gaps inserted into the data by strains with non-base insertions (N instead of 
A, T, C, or G).  Strains without geographic information or the year of collection were 
removed. If no day information was available then the strain was assigned to the 15th of that 
month; if day and month information was missing then the strain was assigned to the first of 
July of that year. Duplicate strains were removed in RAxML and the oldest strain was 
retained (Stamatakis, 2014). TempEst (http://tree.bio.ed.ac.uk/software/tempest/) was used to 
identify outliers and investigate the temporal structure or signals of molecular clock in the 
dataset (Rambaut, et al., 2016). 
After outliers were removed from the dataset, the temporal and geographic 
distributions of RSV A and RSV B were analyzed in Tableau (https://www.tableau.com/) and 
it was determined that subsampling was necessary. Across several years, some countries 
were overrepresented in the data, which were then selected for subsampling. We defined 
overrepresentation as having more than 25 strains for RSV A and more than 20 strains for 
RSV B from one country in any given year. The selection of strains to be included in the 
subsample was conducted by randomly selecting accession numbers from the 
overrepresented groups to get the sample sizes above. Two subsampled datasets were 
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generated for both RSV A and B for the purpose of sensitivity analysis and quality control. 
Strains that were not selected were excluded from further analysis to reduce sampling bias in 
the dataset. 
Maximum Likelihood Phylogenetic Analysis 
A maximum likelihood (ML) tree to preliminarily explore the phylogeny in the full 
dataset was generated in RAxML using the General Time Reversible (GTR) nucleotide 
substitution model with GAMMA distribution of rate heterogeneity among sites. The two 
subsampled datasets were also run through RAxML using the same substitution model. The 
resulting ML trees estimated the time to most recent common ancestor (tMRCAs) and the 
substitution rates were compared to each other and to the full dataset, in order to check the 
quality of the subsampling strategy. To evaluate the reliability of tree topologies, 
bootstrapping analyses were conducted with the extended majority rule consensus tree 
criterion (that is, autoMRE option in RAxML) which automatically determines the sufficient 
bootstrap replicates for getting stable support values. Trees rooted with mid-point root were 
visualized and colored in FigTree v1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/). 
Bootstrapping values were shown on the tree nodes.  
Bayesian Phylogenetic Analysis 
The phylogeny of the subsampled datasets was reconstructed using Bayesian Markov 
chain Monte Carlo (MCMC) methods in the Bayesian Evolutionary Analysis by Sampling 
Trees (BEAST) v1.8.4 with the ML trees as starting trees (Drummond, et al., 2012). The tree 
topology, the evolutionary rates and tMRCAs were co-estimated. HKY nucleotide 
substitution model with GAMMA distribution of rate heterogeneity among sites was used to 
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depict the pattern of nucleotide changes (Hasegawa, Kishino, & Yano, 1985). The 
uncorrelated log-normal relaxed clock model was used to calibrate time information on tree 
branches (Drummond, et al., 2006). Due to computing constraints, a constant coalescent prior 
was used for the global datasets (Drummond, et al., 2002). To generate a set of empirical 
trees, two independent MCMC analyses with chain length of 150 million were run until 
reaching good convergence, with sampling every 15,000th generation and resulting in 10,000 
states or trees output in log and tree files, respectively. The empirical trees for RSV A and 
RSV B were then used for the global transmission analysis. Tracer v1.7 was then used to 
visualize and assess how well these runs have converged; the convergence of combined 
chains from two runs was determined to be acceptable when the estimated effective sample 
size (ESS) > 200 after removing the burn-in (Rambaut, et al., 2018). With well-converged 
runs, log and tree files from these runs were combined in BEAST LogCombiner. Then 
BEAST TreeAnnotator was used to annotate one maximum clade credibility (MCC) tree 
from the combined tree file. Uncertainty from Bayesian analysis was indicated by 95% 
highest posterior density (95% HPD) also called the 95% Bayesian Credible Interval. The 
estimated tMRCA and evolutionary rate were reported with mean value and 95% HPD, 
respectively.  
Discrete phylogeographical analysis   
To make inferences about global transmission dynamics and to guarantee sufficient 
samples in each geographic discrete trait, collection location (country) of each sequence was 
coded into six regions defined by the World Bank: East Asia and Pacific (EAP), Europe and 
Central Asia (ECA), Latin America and Caribbean (LAC), Middle East and North Africa 
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(MEN), South Asia (SA), Sub-Saharan Africa (AF) (World Bank Group, 2018). High income 
countries, which are not categorized by the World Bank, were added to the nearest region. In 
the results, Western Europe was categorized as a part of ECA, and Australia was in EAP. 
The United States and Canada (UC) region was created as an additional region. Houston and 
Chile were categorized as additional regions to assess transmission into and out of these 
locations, resulting in a total of nine regions as the discrete geographic traits. With the same 
substitution model, molecular clock and coalescent models from the previous section 
(“Bayesian Phylogenetic Analyses”), the Bayesian stochastic search variable selection 
(BSSVS) approach was applied to the sets of empirical trees generated above to find a 
parsimonious set of rates explaining the geographic diffusions in the phylogeny. Three runs 
with a chain length of 100 million were conducted. The process for checking convergence 
and combining the runs was similar to the procedure outlined above.  
 The BSSVS approach enabled us to construct a Bayes factor (BF) test to identify 
significant diffusion processes between discrete geographic traits (Lemey, et al., 2009). The 
criteria for significance of the BFs were in accordance with Kass and Raffery’s definition: 
BF≥3 is considered significant (1995). We further categorized the level of support into five 
groups: 3≤BF<6 as weak supported, 6≤BF<10 as substantial support, 10≤BF<30 as strong 
support, 30≤BF<100 as very strong support, and BF≥100 as decisive support (Bahl, et al., 
2013). Transmission pattern and BF results were visualized using SpreaD3 (Bielejec, et al., 
2016). 
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Furthermore, to quantify how many times the transmissions occurred between geo-
regions, Markov jump counts for each node of the ancestral reconstruction were assessed 
based on the global tree (Minin & Suchard, 2008). A non-reversible model was used to 
determine the directionality of the transmission, so that an asymmetric matrix was 
constructed to assess source-sink dynamics among the sampled geo-regions. Heat maps to 
represent the estimated jump counts between two locations were used to show the 
connections of geo-regions.   
Bayesian Tip-Association Significance Testing Analysis 
To explore the correlation between viral genetic characteristics and disease severity, 
the subset of data from Houston and Chile during 2010-2014 with disease severity 
information was used to conduct clustering analysis. G, F and SH genes were linked and 
analyzed as one set in the BEAST phylogenetic analysis. The uncorrelated log-normal 
relaxed clock model and HKY nucleotide substitution model with GAMMA distribution 
were used for the analysis of the local data (Hasegawa, Kishino, & Yano, 1985; Drummond, 
et al, 2006). For the local data, the GMRF Bayesian Skyride with time-aware smoothing 
process was used as the coalescent prior to accommodate changes in the effective population 
size (Minim, Bloomquist, & Suchard, 2008; Drummond, et al., 2002). The chain length was 
set to 100 million with sampling every 10,000th generation, and three runs were conducted. 
LogCombiner and BEAST TreeAnnotator were used to combine the log files and create one 
MCC tree.   
The MCC tree generated in BEAST for the data from Chile and Houston was 
analyzed further in Bayesian Tip-association Significance testing (BaTS) to determine if 
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there is a relationship between disease severity and tree topology (Parker, Rambaut, & Pybus, 
2008). Disease severity traits, analyzed as dichotomous variables, included if oxygen therapy 
was needed, if they were admitted to the hospital, and if they had to be admitted to an 
intensive care unit (ICU). These traits were analyzed together, and also separately to identify 
the association between single disease severity trait and genetic characteristics. A single 
configuration was run in the BaTS program, where an Association Index (AI), Finch’s 
parsimony score (PS), and a monophyletic clade (MC) size statistic were calculated to 
determine the strength of association. The AI tests for the consistency of a trait across 
internal nodes of the tree, and a lower number represents a stronger relationship between tree 
topology and the trait of interest. The PS takes into account the number of trait changes 
beyond each ancestral node, where the score is reported as an integer and lower numbers 
indicate a stronger relationship between the trait and tree structure. The MC statistic assumes 
that if a clade is monophyletic for the trait of interest, then the MC value is high and the 
relationship between tree topology is strong. Clusters that are significantly correlated with 
high disease severity were reported with the corresponding p-value.  
Ethics Statement 
All data used in this study were de-identified before we received the datasets from 
Chile and Houston. No further medical or demographic information was collected from these 
patients, and we did not have access to their medical records. The original data collection in 
Chile and Houston was carried out with IRB approval. Publicly available data from GenBank 
does not include protected health information or personal identifiers of patients from which 
22 
 
the samples were isolated. The protocol for this secondary data analysis was submitted for 
IRB approval within the University of Texas Health system and determined to be exempt.  
 
RESULTS 
Global Transmission Dynamics  
Global Distribution of RSV Samples 
 Originally, 1,186 RSV A sequences were downloaded from GenBank and 143 
samples came from collaborators in Chile and Houston. For RSV B, 486 sequences were 
downloaded from GenBank and 107 came from study collaborators. After removing 
duplicates, lab strains, and outliers, there were 1,123 RSV A sequences and 568 RSV B 
sequences (see Figures A1a and A1b for global distribution of these samples). After 
subsampling, there were 739 RSV A sequences and 474 RSV B sequences included in the 
analyses. Of 739 RSV A sequences, 54 were from Chile and 67 were from Houston. Of the 
474 RSV B sequences, 44 taxa were from Chile and 37 were from Houston. By geo-region, 
the vast majority of RSV A sequences were from the UC region (n=284), as were the 
majority of RSV B sequences (n=178). EAP (n=115) was the second most common region in 
the RSV A dataset, and ECA (n=74) was the second most common region among the RSV B 
samples. SA was the least common region; only two RSV A sequences came from SA, and 
no RSV B sequences came from this region (see Figures 1a and 1b for the distribution of 
sequences by geo-region). 
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Figure 1. Distribution of Subsampled Sequences by Geo-Region  
 
 
The number of RSV A (a) and B (b) sequences from each of the adapted World Bank regions included in the 
subsampled dataset for further analyses. 
 
  
Bayesian Phylogenetic Analysis  
 The MCC trees for RSV A and B were generated and coded by geo-region to make 
inferences about global transmission dynamics. The MCC tree for RSV A (Figure 2) has two 
large clusters that have been co-evolving and co-circulating. One cluster is largely made up 
of sequences from the UC region, with some small clusters from Houston, ECA, and LAC. 
The other large cluster was less dominated by the UC region and contained clusters from 
EAP, LAC, and AF. There were also smaller clusters from the MEN, Houston, and Chile. 
The tree shows two major lineages with bushy leaves in the more recent time period, which 
indicates intense sampling efforts in more recent times. Multiple lineages co-circulate over 
time suggesting a higher standing genetic diversity than observed in other RNA viruses 
causing respiratory disease, such as Influenza A virus. The longer branches on the older part 
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of the tree indicate that there was missing information, probably due to a lack of RSV 
surveillance, which increases the uncertainty of the tMRCA estimation. The RSV A tMRCA 
for the sample of publicly available data and the clinical data from Chile and Houston was 
estimated to be 1963.40 (95% BCI: 1946.15, 1969.60), with a mean substitution rate of 
7.43x10-4 substitutions/site/year. This is a relatively wide Bayesian credible interval, 
indicating the uncertainty of the estimation is increased by missing data at early stages of 
RSV surveillance.   
Figure 2. Bayesian Maximum Clade Credibility Tree for Global RSV A  
 
The MCC tree for RSV A color coded by geo- region. High income countries were added to the closest region, 
and the United States and Canada was added as another region.  
 
25 
 
The RSV B MCC tree (Figure 3) has a pronounced ladder shaped phylogeny with 
bushy leaves. Similar to the RSV A tree, there has been intensive surveillance in more recent 
times. In contrast, all co-circulating RSV B lineages have a more recent common ancestor 
from 2000.90 (95% BCI: 2000.88, 2001.93). The RSV B tree also has some long branches, 
which indicates that data is missing from the globally available dataset. The older clusters are 
mostly from the UC. The more recent clusters are mainly composed of strains from ECA, 
with smaller clusters from Chile, AF, EAP, and the UC. The RSV B tMRCA was 1963.80 
(95% BCI: 1959.50, 1967.33) with a mean substitution rate of 8.34x10-4 
substitutions/site/year. The Bayesian credible interval is relatively smaller, so this estimate 
has less uncertainty.  
Figure 3. Bayesian Maximum Clade Credibility Tree for Global RSV B 
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The MCC tree for RSV B color coded by geo-region. High income countries were added to the closest region, 
and the United States and Canada was added as another region. 
 
RSV Global Transmission Patterns 
The transmission rates and Bayes factors were generated to identify potentially 
important transmission routes on the global level. The key transmission routes for RSV A 
(Figure 4 and Table B1) were from ECA to LAC, EAP, AF, and EAP to MEN. These routes 
had the highest transmission rates (2.666, 2.086, 1.343, and 1.678 transitions per year, 
respectively) and had decisive statistical support (BF>100). ECA to the UC also had one of 
the highest transmission rates (2.523) but was not supported (BF<3).  
Figure 4. Map of Global Transmission Rates for RSV A 
 
Map of global transmission patterns for RSV A. Only transmissions with BF≥3 are shown. The color of the line 
indicates the level of support, and the weight of the line indicates the rate of transmission with thicker lines 
indicating a higher rate. Arrowheads indicate the direction of transmission. UC is the United States and Canada 
region, LAC is Latin America and the Caribbean, ECA is Europe and Central Asia, MEN is the Middle East and 
North Africa, AF is Sub-Saharan Africa, SA is South Asia, and EAP is East Asia and the Pacific. 
 
Transmission from LAC into Houston was weakly supported (3≤BF<6) and the rate 
was low (0.584 transitions per year). There was substantial support (6≤BF<10) for Houston 
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as a sink for EAP at a rate of 0.515 transitions per year. MEN and AF were strongly 
supported (10≤BF<30) sources of virus for Houston (0.841 and 0.425 transitions per year, 
respectively). Transmission routes from SA and ECA to Houston had decisive support 
(BF≥100), although the rate from SA (0.289 transitions per year) was much lower than the 
one from ECA (1.438 transitions per year). Houston was a very strongly supported 
(30≤BF<100) source of infection to MEN (0.787 transitions per year).  
Transmission from Chile to SA and from Chile to EAP is weakly supported 
(3≤BF<6), and rates for these transmissions were low (0.192 and 0.767 transitions per year, 
respectively). ECA was a substantially supported source of infection for Chile, at a rate of 
0.666 transitions per year, and EAP into Chile was strongly supported at a rate of 0.711 
transitions per year. There was decisive support for SA and LAC as sources of infection for 
Chile. The rate of transmission from LAC into Chile was 1.500 transitions per year, the 
highest rate of all transmissions involving Chile, and the rate from SA was very low (0.269 
transitions per year). Chile was a very strongly supported source of infection for ECA, with a 
rate of 1.476 transitions per year.  
In RSV B (Figure 5 and table B2), transmission routes from ECA to UC and to EAP 
had the highest rates (2.854 and 2.815 transitions per year, respectively), and these routes had 
decisive support (BF>100). Routes from ECA to AF, Chile, LAC, and MEN all have 
decisive support as well, although the rates are lower (0.500, 1.270, 1.620, and 1.398 
transitions per year, respectively). Transmission from MEN has strong support to Houston. 
Transmissions from LAC and ECA to Houston are very strongly supported. There is decisive 
support for transmission from the UC to Houston at a rate of 0.628 transitions per year and to 
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Chile at a rate of 1.27 transitions per year, and from Houston to the UC at a rate of 1.58 
transitions per year.  
Figure 5. Map of Global Transmission Rates for RSV B 
 
Map of global transmission patterns for RSV B. Only transmissions with BF≥3 are shown. The color of the line 
indicates the level of support, and the weight of the line indicates the rate of transmission with thicker lines 
indicating a higher rate. Arrowheads indicate the direction of transmission. UC is the United States and Canada 
region, LAC is Latin America and the Caribbean, ECA is Europe and Central Asia, MEN is the Middle East and 
North Africa, AF is Sub-Saharan Africa, and EAP is East Asia and the Pacific. 
 
Markov Jump Counts 
The complete history of the Markov jump counts was reconstructed to quantify jump 
events in a source-sink model. For global RSV A (Figure 6), the average number of 
transmissions between regions (“jump counts”) were highest from ECA to LAC (19.90), 
from ECA to the UC (18.62), and from the UC to Chile (17.94). AF, Houston, MEN, SA 
were the least common sources of transmissions. ECA was the most common source but not 
a major sink for any region. The most common source of transmission to Chile was the UC 
region. Chile was the most common source of transmission for ECA at an average of 5.93 
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jumps. ECA and the UC were the most common sources of transmission for Houston, at 9.96 
and 7.76 jumps, respectively. Houston was not a common source for any of the geo-regions.   
Figure 6. Markov Jump Count Heat Map for RSV A 
 
Darker colors indicate a higher average number of jumps from the source location (origin of transmission) to 
the sink location (destination of the transmission). A red star by the average number of jumps indicates that the 
transmission route has a BF≥3 meaning that it is supported.  
 
For the global RSV B (Figure 7), we observed that ECA was the most common 
source of transmission, with the average number of jumps being highest to the UC (32.63), to 
EAP (32.39), and to LAC (18.16). AF, Chile, EAP, LAC, and MEN were rarely the source of 
transmissions. The UC was the most common sink. The UC and ECA were the most 
common sources of transmission for Chile, with average jump counts of 16.49 and 6.39, 
respectively. Chile was not a major source of transmission for any of the geo-regions. The 
main sources of transmission into Houston were the same as those for Chile. Houston was a 
source of transmission for the UC (8.95), although it was not the major source for UC.  
Figure 7. Markov Jump Count Heat Map for RSV B  
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 Darker colors indicate a higher average number of jumps from the source location (origin of transmission) to 
the sink location (destination of the transmission). A red star by the average number of jumps indicates that the 
transmission route has a BF≥3 meaning that it is supported.  
 
 
Clinical Severity Analyses 
Clinical Data Description 
Clinical data from Chile and Houston was used to explore associations between viral 
genetic characteristics and disease severity. After cleaning the data, for RSV A, 60 taxa with 
clinical data from Chile and Houston were used. Twenty-three of the sequences were from 
Chile and 37 were from Houston. For RSV B severity, 41 taxa were from Chile and Houston. 
Thirty-one of the sequences were from Chile and 10 were from Houston. Detailed 
distribution and disease severity traits are in Table 1.  
Table 1. Number of Cases by Disease Severity Traits for RSV A and RSV B  
Disease Severity Traits Number of RSV A 
Cases 
Number of RSV B 
Cases 
Oxygen, Hospitalized, Admitted to ICU 7 4 
Oxygen, Hospitalized, Not Admitted to ICU 24 30 
No Oxygen, Hospitalized, Admitted to ICU 2 0 
No Oxygen, Hospitalized, Not Admitted to ICU 11 4 
No Oxygen, Not Hospitalized, Not Admitted to 
ICU 
16 3 
 
Bayesian Phylogenetic Analysis of Clinical Data 
In order to analyze the association between topologies and clinical traits in BaTS to 
identify clustering patterns, MCC trees were generated using BEAST. The trees for the RSV 
A and RSV B (Figures 8 and 9) clinical data do not exhibit the same ladder shape as the 
global trees, but both have bushy leaves, indicating intensive sampling for outbreaks at each 
location. Both trees have long branches, which indicates that missing data exist. The clades 
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of the RSV A tree are closely tied to the geographic origin, with two clades from Houston 
and one clade from Chile. The geographic origins are more interspersed in the RSV B tree, 
but there are very few sequences from Houston, where the unrepresented samples may 
explain the mixing. The RSV A clade from Chile is dominated by the “oxygen, hospitalized, 
not admitted to the ICU” severity traits. While the clades from Houston have a mixture of 
severity traits, with the “no oxygen, not hospitalized, not admitted to the ICU” trait making 
up the majority of cases. The estimated tMRCA for the clinical RSV A tree was 2007.78 
(95% BCI: 2006.54, 2009.05) with a mean substitution rate 1.493x10-3 
substitutions/site/year. The Bayesian credible interval is relatively narrow, so the tMRCA 
estimate is more certain.  
Figure 8. Clinical Maximum Clade Credibility Trees for RSV A  
 
The MCC tree for RSV A from Chile and Houston color coded by severity traits: whether the patient was given 
oxygen therapy, whether they were hospitalized, and whether they were admitted to the intensive care unit. 
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Figure 9. Clinical Maximum Clade Credibility Trees for RSV B 
 
The MCC tree for RSV B from Chile and Houston color coded by severity traits: whether the patient was given 
oxygen therapy, whether they were hospitalized, and whether they were admitted to the intensive care unit. 
 
For the RSV B clinical data the tMRCA was estimated to be 2001.35 (95% BCI: 
1995.01, 2006.41) with a mean substitution rate of 9.562x10-4 substitutions/site/year. Unlike 
the RSV A Bayesian credible interval, the RSV B interval is quite wide so there is a large 
degree of uncertainty in the tMRCA estimate, which is probably due to missing data. The 
vast majority of sequences in the RSV B had the “oxygen, hospitalized, not admitted to the 
ICU” trait and they tended to be within the same cluster. The other severity traits were rare 
and were interspersed throughout the clades of the tree.  
Clustering Analysis of Clinical Severity 
Using BaTS, an analysis of the association between disease severity traits and viral 
genetic characteristics was conducted. For the RSV A samples, the BaTS analysis yielded a 
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significant association between the clinical traits and the phylogeny of the tree when all three 
traits were combined (needed oxygen, hospitalized, and admitted to the ICU). The cluster 
analysis yielded significant results when oxygen therapy and hospitalization were analyzed 
separately. There were no significant associations between clinical traits and the tree 
phylogeny for ICU admittance in RSV A. The RSV A AI and PS statistics, which assess all 
traits, were significant (Table 2). The significant AI statistic indicates that the traits are 
consistent across the internal nodes of the tree, and the significant PS indicates that the 
number of trait changes through the ancestral nodes is small. However, not all of the MC 
statistics, where each variant of the trait is assessed individually, were significant. The MC 
statistic was significant for the “oxygen, hospitalized, not admitted to the ICU” trait and the 
“no oxygen, not hospitalized, not admitted to the ICU”, indicating that these traits have larger 
monophyletic clades and therefore are associated with the phylogeny of the tree but the other 
traits are not.  
Table 2. Clustering of Disease Severity Traits for RSV A 
RSV A Combined Clinical Traits 
Statistic Observed Mean Significance 
AI 3.127 <0.01* 
PS 22.392 <0.01* 
MC (Oxygen, Hospitalized, No ICU) 5.593 0.02* 
MC (Oxygen, Hospitalized, ICU) 1.601 1 
MC (No Oxygen, Hospitalized, No ICU) 1.679 0.13 
MC (No Oxygen, Not Hospitalized, No ICU) 3.444 0.01* 
MC (Oxygen, Hospitalized, ICU) 1 1 
Oxygen Therapy 
AI 0.983 0.00* 
PS 9.318 0.00* 
MC (Oxygen) 6.259 0.02* 
MC (No Oxygen) 7.464 0.03* 
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Hospitalized 
AI 1.917 0.01* 
PS 11.784 0.01* 
MC (Hospitalized) 19.210 0.01* 
MC (Not Hospitalized) 3.444 0.03* 
Admitted to ICU 
AI 1.567 0.32 
PS 8.116 0.13 
MC (No ICU) 8.985 0.47 
MC (ICU) 1.651 0.05 
*indicates the null hypothesis can be rejected at a significance level of 0.05. 
 
For RSV B, no significant associations between clinical traits and phylogeny were 
found when analyzing all three traits together and each independently (Table 3).  
Table 3. Clustering of Disease Severity Traits for RSV B  
RSV B Combined Clinical Traits 
Statistic Observed Mean Significance 
AI 1.613 0.06 
PS 10.722 1 
MC (Oxygen, Hospitalized, No ICU) 5.795 0.46 
MC (No Oxygen, Hospitalized, No ICU) 1 1 
MC (Oxygen, Hospitalized, ICU) 1 1 
MC (No Oxygen, Not Hospitalized, No ICU) 1.154 1 
Oxygen Therapy 
AI 1.038 0.16 
PS 6.735 1 
MC (Oxygen) 6.473 0.58 
MC (No Oxygen) 1.154 1 
Hospitalized 
AI 1.038 0.18 
PS 6.735 1 
MC (Hospitalized) 6.473 0.57 
MC (Not Hospitalized) 1.154 1 
Admitted to ICU 
AI 0.819 0.49 
PS 4 1 
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MC (No ICU) 6.327 0.98 
MC (ICU) 1 1 
*indicates the null hypothesis can be rejected at a significance level of 0.05 
 
 
DISCUSSION 
Although RSV usually presents with mild, flu-like symptoms, it can cause severe 
disease outcomes for infants, especially premature infants, and adults over the age of 65. In 
the absence of an FDA-approved vaccine that is widely available, outbreak prevention and 
control relies on a firm understanding of transmission patterns and dynamics. Since vaccine 
candidates and antiviral treatment are being developed, it is important to identify viral 
genetic characteristics that can predict disease severity and be better targets. The aim of this 
study was to use RSV full-genome sequence data to gain a better understanding of the global 
transmission patterns, the transmission of RSV into and out of Houston and Chile and to 
preliminarily test if there are viral characteristics within the F, G, and SH genes associated 
with higher severity of disease. To our knowledge, this is the first study to use full genome 
data to model and identify RSV global transmission patterns. While other studies have 
implied that global transmission dynamics are important for regional and local outbreaks, 
very few have tried to elucidate those dynamics, and those studies have relied on solely on 
the short sequences of the G gene (Hibino, et al., 2018; Giallonardo, et al., 2018). This is also 
the first effort to link characteristics of the three surface proteins to patient outcomes, as 
previous studies have focused on RSV genotypes or patient characteristics (Hibino, et al., 
2016; Yoshihara, et al., 2016; Panayiotou, et al., 2014). 
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With the estimation from phylogenetic modeling, we estimated that the tMRCA of 
RSV A was 1963.40 and the mean substitution rate was 7.43x10-4 substitutions/site/year. Zou 
and colleagues reported the tMRCA for the GA2 and GA7 genotypes, which they estimated 
to be 1965 (95% HPD: 1970-1975) with a substitution rate of 2.3x10-3 (Zou, et al., 2016). 
The phylogenetic tree generated by Zou and colleagues appears to have a similar shape to the 
tree we generated for RSV A. The tree shape for RSV A is also similar to the phylogenetic 
trees generated in the Elawar, Schobel, and Agoti studies (Elawar, et al., 2017; Schobel, et 
al., 2016; Agoti, et al., 2017). The tMRCA from the Zou tree appears to be around 1965, 
which is within our 95% BCI (1946.15, 1969.60). The huge differences in the substitution 
rates may be due to the differences in the data examined. Zou and colleagues just looked at G 
gene data, which is shorter and includes a hypervariable region, while our study looked at all 
the currently available full genome data, which may result in a more accurate substitution 
rate over the full length of the genome. Agoti and colleagues found a substitution rate of 
4.95x10-3 in their study of household transmission dynamics when looking at full genome 
data (Agoti, et al., 2017). A study conducted by Giallonardo and colleagues (2018) also 
looked at full sequence data, and their estimate of the substitution rate using BEAST was 
7.48x10-4 substitutions/site/year for RSV A and 7.39x10-4 substitutions/site/year for RSV B. 
Their estimate for RSV A is very similar to the one we have reported here. Since few studies 
have focused on RSV B, this study, in addition to the Giallonardo study, provides 
preliminary estimates of the evolutionary dynamics of RSV B with tMRCA estimated as 
1963.80 and the mean substitution rate as 8.34x10-4 substitutions/site/year.  
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The results from the global transmission modeling showed that for both RSV A and 
B, ECA was an important source of transmission events for many regions, including Houston 
and Chile. Although the rate of transmissions from ECA to UC was high for RSV A, it was 
not found to be significant for RSV A. This may be due to the scarce samples from ECA over 
years, resulting in insufficient statistical power to detect the significance, though the 
transmission rates showed the potential close relationships between these two locations. For 
Houston, LAC and MEN were also important sources of RSV A and B transmission. A 
potential mechanism for RSV global introductions is air travel, which provides pathogens a 
quick way to reach all corners of the globe. RSV is mainly transmitted through fomites and 
droplets (Kutter, et al., 2018). Although RSV does not spread as efficiently as an aerosol 
(e.g., influenza), transmission could still occur in a small, enclosed space, such as an 
airplane. In 2017, 54.2 million people flew into Houston area airports, and of these 
passengers, 11.2 million came from international airports (Houston Airport System, 2018). 
Houston is the fourth largest city in the United States and is a key business center for the 
global oil and gas industry. At Nuevo Paudahuel, the main airport for Santiago, Chile, close 
to 50% of the 1.23 million passengers are from international origins (Aeropuerto de Santiago, 
2015). The large number of people travelling from around the globe facilitates many 
potential RSV introductions.  
 Studies of influenza have indicated that air travel patterns paired with information on 
seasonal peaks of influenza outbreak help explain its global transmission patterns (Kenah, et 
al., 2011). A similar phenomenon could be happening with RSV. The peak of RSV in Texas 
is usually in December or January, with the number of cases starting to increase in September 
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or October (Texas Department of State Health Services, 2018). This peak season overlaps 
with peaks in the ECA and MEN regions, which may explain why these transmission routes 
are supported (Hendaus, et al., 2018; Sricharoenchai, Palla, & Sanicas, 2016). The peak in 
LAC varies since the region includes countries in the northern and southern hemisphere with 
both temperate and tropical climates. Within the region, RSV peaks in Mexico would overlap 
with the peaks in Houston, but the peaks for Peru, Chile, and Argentina would occur in June, 
July, and August (Rodriguez-Auad, et al., 2012; Sricharoenchai, Palla, & Sanicas, 2016), 
while the tropical locations in LAC with year-round outbreak may facilitate the seasonality 
of both hemispheres. Peaks in Brazil occur over a wide range of time periods that correspond 
to the rainy season, with slight overlap with the peaks in Texas (Sricharoenchai, Palla, & 
Sanicas, 2016). The peak season overlap does not fully explain transmission from ECA to 
Chile since they have opposite peak seasons, but the intermediate links in the tropical areas 
may contribute the transmission between LAC and Houston. Further studies are needed to 
investigate this connection. 
Many studies have taken a genotype-specific approach to RSV phylogeny and focus 
on the evolution of each genotype. Zou and colleagues were one of the first to try to 
determine the global transmission of RSV A, but they did not investigate transmission routes 
(Zou, et al., 2016). Their analysis from genotypes GA2 and GA7 supported the potential of 
substantial international movement of RSV lineages although it was not detected in their 
current dataset. Our results of RSV global transmission patterns, which focus on the 
evolution of all genotypes, support the idea from Zou and Elawar, as well as studies of local 
transmissions (Zou, et al., 2016; Elawar, et al., 2017). Therefore, our study with a more 
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complete RSV global dataset adds more evidence to the hypothesis that international 
transmission events are key to RSV transmission patterns as many routes are statistically 
supported in our study. 
With the clinical disease severity data from Houston and Chile, we identified a 
significant association between the RSV A tree topologies and disease severity. We did not 
identify any significant associations in RSV B, which may be due to the small sample size of 
the clinical dataset. It is important to note that the clinical RSV dataset only includes the 
main circulating genotypes (two RSV A genotypes: GA2 and ON, and one RSV B genotype: 
BA), so it may not represent the complete picture of RSV epidemics. Although we did not 
analyze the data by genotype, the clusters associated with more severe outcomes are in the 
ON clade for RSV A. This association between the ON genotype and increased severity was 
also reported in the Hibino and Yoshihara studies, although both of these studies compared 
ON to NA1, and not to GA2. Since we had only one genotype of RSV B, we cannot compare 
it to the studies that took a genotypic approach.  
Our preliminary analysis on disease severity provides some insights on data 
collection and future directions. It would be ideal to collect a larger number of samples for 
both RSVA and B from patients on both ends of the severity spectrum, those who did not go 
to the hospital and those who had to be admitted to the ICU. It would also be better to have 
multiple genotypes represented within the sample for easier comparison to previous studies 
that related RSV genotype to disease severity. In our analysis, we did not include data on 
patient characteristics and other confounding variables that could impact outcome severity 
(e.g., patient age or whether they have co-morbidities) or the patients’ viral loads. While this 
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preliminary analysis indicates that there are genetic characteristics associated with disease 
severity, further analyses should take viral load and patient characteristics into account to 
control for these potential confounders. Further studies should also conduct a scan of the 
genomes for clades significantly associated with severe outcomes to determine what 
variations are associated with more severe outcomes. Identifying critical mutations that lead 
to more severe outcomes, and determining how these outcomes are correlated with patient 
genetics, can help inform antiviral medication and vaccine development. 
This study has some limitations. First, the global data have obvious sampling biases. 
The United States and Canada (UC) region are heavily overrepresented in the dataset, while 
other regions may only have very scarce samples over countries or over years. For example, 
data from Latin American and the Caribbean (LAC) and Sub-Saharan Africa (AF) represent 
only one or two countries within that region, data from Europe and Central Asia (ECA) 
mainly have samples only for a few years, and South Asia (SA) is not represented at all in the 
RSV B dataset. The US in general is heavily overrepresented across both datasets and across 
all years, although a large portion of the data from the US comes for a few cohort studies 
conducted in localized areas, and so may not be representative of the US as a whole. To 
reduce the selection bias in the data, we have subsampled the data by country and year and 
conducted sensitivity analysis with multiple subsampled datasets. Another key limitation is 
related to using geo-regions to infer transmission dynamics. World Bank regions may be 
represented by only one or two countries within that region, so the data may not reflect the 
true dynamics of transmission; that is, we cannot determine if the routes are direct, neither 
can we determine the intermediate stops within each of those regions. However, inferences 
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drawn from using geo-regions may help us identify key regions where surveillance efforts 
need to be increased. Furthermore, some of the disease severity data may not be accurate. For 
example, it is unlikely that someone was admitted to the hospital and the ICU for a 
respiratory infection but was not given oxygen, but a few of these cases were reported. 
Without direct access to patient records, it is impossible to verify the medical treatments 
required by each patient. Another limitation of the severity data is the small sample size for 
RSV B, which means we are likely underpowered to detect an association between disease 
severity and tree topology if an association does exist. Further studies, with more data are 
needed to determine if the associations for RSV B are similar to RSV A.  
Better surveillance systems to routinely collect global representative samples are 
needed in many parts of the world in order to gain an unbiased understanding of global 
transmission dynamics. A system proposed by the WHO would help collect more complete 
datasets that are more representative of the viral variation around the world (WHO, 2017). 
This in turn would lead to more robust inferences on transmission dynamics to determine the 
importance of within region persistence and global transmission routes. Further studies of 
global transmission dynamics with a more representative dataset could be improved with 
more sophisticated population coalescent models. For disease severity, studies need to be 
conducted with sequence scans to identify key mutations associated with increased severity.  
 
CONCLUSION 
In summary, though data limitations exist, with rigorous subsampling strategy, 
phylodynamic modeling and clustering analysis, we were able to depict the global 
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transmission patterns of RSV. The ECA region was an important source of RSV A and B 
transmission for Chile and Houston, so increased surveillance in this region may help predict 
the main genotype of seasonal outbreaks in Chile and Houston, and eventually help guide 
vaccine design. Even before a vaccine is available, information about transmission dynamics 
can be used to help control the spread of the disease. There was an association between tree 
topology and disease severity for RSV A. More data and further studies are needed to 
identify which genetic variants are associated with this increased severity.   
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APPENDICES 
Appendix A:  Distribution of Global RSV Samples  
Figure A1. Distribution of Sequences by Geo-Region for RSV A(a) and RSV B(b) 
 
 
The number of RSV A (a) and B (b) sequences from each of the adapted World Bank regions included in the 
full dataset. 
 
 
Appendix B:  Transmission Rates for RSV and Level of Support 
Table B1. Rates and Level of Support for RSV A Transmission  
From To 
Mean 
Rate* 
Median 
Rate 
HPD 
lower 
HPD 
upper 
Bayes 
Factor 
Europe & Central 
Asia 
Latin America & the 
Caribbean 2.666 2.554 1.211 4.362 >100 
East Asia & the 
Pacific 
United States & 
Canada 2.556 2.460 1.061 4.399 >100 
Europe & Central 
Asia 
East Asia & the 
Pacific 2.086 1.983 0.644 3.486 >100 
East Asia & the 
Pacific 
Middle East & North 
Africa 1.678 1.578 0.567 3.036 >100 
Latin America & the 
Caribbean Chile 1.500 1.387 0.345 2.860 >100 
Chile 
Europe & Central 
Asia 1.476 1.395 0.072 2.915 38.003 
Europe & Central 
Asia Houston 1.438 1.366 0.427 2.597 >100 
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Europe & Central 
Asia Sub-Saharan Africa 1.343 1.276 0.473 2.319 >100 
Europe & Central 
Asia 
Middle East & North 
Africa 0.972 0.915 0.110 1.878 53.576 
Middle East & North 
Africa Houston 0.841 0.746 0.044 1.786 34.560 
Middle East & North 
Africa 
East Asia & the 
Pacific 0.832 0.708 0.051 1.877 71.613 
Houston 
Middle East & North 
Africa 0.787 0.651 0.005 1.896 35.657 
Chile 
East Asia & the 
Pacific 0.767 0.679 0.008 1.736 5.120 
East Asia & the 
Pacific Chile 0.711 0.623 0.054 1.570 13.105 
Europe & Central 
Asia Chile 0.666 0.599 0.026 1.473 8.213 
Middle East & North 
Africa 
Latin America & the 
Caribbean 0.616 0.510 0.007 1.556 5.250 
Latin America & the 
Caribbean Houston 0.584 0.485 0.011 1.487 4.499 
East Asia & the 
Pacific Houston 0.515 0.425 0.019 1.252 7.493 
East Asia & the 
Pacific 
Latin America & the 
Caribbean 0.497 0.420 0.010 1.178 6.512 
East Asia & the 
Pacific South Asia 0.468 0.405 0.034 1.063 >100 
Sub-Saharan Africa Houston 0.425 0.338 0.011 1.034 75.713 
South Asia 
East Asia & the 
Pacific 0.345 0.230 0.001 0.945 10.678 
South Asia 
Latin America & the 
Caribbean 0.296 0.184 0.000 0.933 23.900 
South Asia Houston 0.289 0.202 0.000 0.858 >100 
South Asia Chile 0.269 0.201 0.000 0.809 >100 
South Asia 
Europe & Central 
Asia 0.256 0.187 0.001 0.746 5.626 
Latin America & the 
Caribbean South Asia 0.192 0.116 0.002 0.827 18.069 
Chile South Asia 0.192 0.155 0.001 0.710 3.867 
Europe & Central 
Asia South Asia 0.187 0.174 0.031 0.437 >100 
*Ordered by the value of rates.  
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Table B2. Rates and Level of Support for RSV B Transmission 
From To 
Mean 
Rate* 
Median 
rate 
HPD 
lower 
HPD 
upper 
BAYES_FA
CTOR 
Europe & Central 
Asia 
United States & 
Canada 2.854 2.745 1.272 4.618 >100 
Europe & Central 
Asia 
East Asia & the 
Pacific 2.815 2.723 1.204 4.547 >100 
Europe & Central 
Asia 
Latin America & the 
Caribbean 1.620 1.553 0.619 2.685 >100 
Houston 
United States & 
Canada 1.584 1.484 0.343 2.979 >100 
Europe & Central 
Asia 
Middle East & North 
Africa 1.398 1.323 0.515 2.439 >100 
United States & 
Canada Chile 1.270 1.195 0.452 2.262 >100 
Middle East & North 
Africa Houston 0.751 0.661 0.017 1.608 23.435 
Europe & Central 
Asia Houston 0.652 0.586 0.045 1.353 89.947 
East Asia & the 
Pacific 
United States & 
Canada 0.642 0.538 0.000 1.618 3.947 
Europe & Central 
Asia Chile 0.632 0.592 0.092 1.260 >100 
United States & 
Canada Houston 0.628 0.562 0.107 1.324 >100 
Latin America & the 
Caribbean Houston 0.571 0.491 0.029 1.321 41.055 
Europe & Central 
Asia Sub-Saharan Africa 0.500 0.452 0.072 1.023 >100 
United States & 
Canada 
Europe & Central 
Asia 0.454 0.408 0.050 0.950 21.471 
*Ordered by the value of rates. 
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